Literature DB >> 17318302

Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation.

Y Baba1, M C Baker, I Le Ber, A Brice, L Maeck, J Kohlhase, M Yasuda, G Stoppe, O Bugiani, A D Sperfeld, Y Tsuboi, R J Uitti, M J Farrer, B Ghetti, M L Hutton, Z K Wszolek.   

Abstract

In 9 patients with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) with a P301S tau mutation, the predominant phenotype was frontotemporal dementia in 3 and parkinsonism in 6. Comparison of the tau genotype/haplotype carrying the mutation and the initial clinical sign showed association between H1/H1 and parkinsonism and between H1/H2 and personality change. Thus, the tau haplotype carrying the mutation and the tau genotype may be related to the clinical phenotype throughout the disease course.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318302     DOI: 10.1007/s00702-007-0632-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

1.  Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

Authors:  O Bugiani; J R Murrell; G Giaccone; M Hasegawa; G Ghigo; M Tabaton; M Morbin; A Primavera; F Carella; C Solaro; M Grisoli; M Savoiardo; M G Spillantini; F Tagliavini; M Goedert; B Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  1999-06       Impact factor: 3.685

2.  A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation.

Authors:  M Yasuda; K Yokoyama; T Nakayasu; Y Nishimura; M Matsui; T Yokoyama; K Miyoshi; C Tanaka
Journal:  Neurology       Date:  2000-10-24       Impact factor: 9.910

Review 3.  Hereditary tauopathies and parkinsonism.

Authors:  Zbigniew K Wszolek; Yoshio Tsuboi; Mathew Farrer; Ryan J Uitti; Mike L Hutton
Journal:  Adv Neurol       Date:  2003

4.  Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family.

Authors:  Alexander Lossos; Avinoam Reches; Aya Gal; Joel P Newman; Dov Soffer; John Moshe Gomori; Moshe Boher; Dana Ekstein; Iftah Biran; Zeev Meiner; Oded Abramsky; Hanna Rosenmann
Journal:  J Neurol       Date:  2003-06       Impact factor: 4.849

5.  FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation.

Authors:  A D Sperfeld; M B Collatz; H Baier; M Palmbach; A Storch; J Schwarz; K Tatsch; S Reske; M Joosse; P Heutink; A C Ludolph
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

6.  Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype.

Authors:  H Houlden; M Baker; H R Morris; N MacDonald; S Pickering-Brown; J Adamson; A J Lees; M N Rossor; N P Quinn; A Kertesz; M N Khan; J Hardy; P L Lantos; P St George-Hyslop; D G Munoz; D Mann; A E Lang; C Bergeron; E H Bigio; I Litvan; K P Bhatia; D Dickson; N W Wood; M Hutton
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

7.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

8.  Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin.

Authors:  Edith Werber; Colin Klein; Jonathan Grünfeld; José Martin Rabey
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

9.  Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy.

Authors:  C Conrad; N Amano; A Andreadis; Y Xia; K Namekataf; F Oyama; K Ikeda; K Wakabayashi; H Takahashi; L J Thal; R Katzman; D A Shackelford; M Matsushita; E Masliah; A Sawa
Journal:  Neurosci Lett       Date:  1998-07-03       Impact factor: 3.046

  9 in total
  13 in total

1.  Prominent phenotypic variability associated with mutations in Progranulin.

Authors:  Brendan J Kelley; Wael Haidar; Bradley F Boeve; Matt Baker; Neill R Graff-Radford; Thomas Krefft; Andrew R Frank; Clifford R Jack; Maria Shiung; David S Knopman; Keith A Josephs; Sotirios A Parashos; Rosa Rademakers; Mike Hutton; Stuart Pickering-Brown; Jennifer Adamson; Karen M Kuntz; Dennis W Dickson; Joseph E Parisi; Glenn E Smith; Robert J Ivnik; Ronald C Petersen
Journal:  Neurobiol Aging       Date:  2007-10-18       Impact factor: 4.673

2.  Parkinsonism and frontotemporal dementia: the clinical overlap.

Authors:  Alberto J Espay; Irene Litvan
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

Review 3.  Parkinsonism, movement disorders and genetics in frontotemporal dementia.

Authors:  José Fidel Baizabal-Carvallo; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2016-02-19       Impact factor: 42.937

Review 4.  Tau and MAPT genetics in tauopathies and synucleinopathies.

Authors:  Etienne Leveille; Owen A Ross; Ziv Gan-Or
Journal:  Parkinsonism Relat Disord       Date:  2021-09-14       Impact factor: 4.402

5.  Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.

Authors:  Magali Dumont; Cliona Stack; Ceyhan Elipenahli; Shari Jainuddin; Meri Gerges; Natalia Starkova; Noel Y Calingasan; Lichuan Yang; Davide Tampellini; Anatoly A Starkov; Robin B Chan; Gilbert Di Paolo; Aurora Pujol; M Flint Beal
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

6.  Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation.

Authors:  Arianna Bellucci; Orso Bugiani; Bernardino Ghetti; Maria Grazia Spillantini
Journal:  Neurodegener Dis       Date:  2011-01-05       Impact factor: 2.977

Review 7.  New perspective on parkinsonism in frontotemporal lobar degeneration.

Authors:  Hee Kyung Park; Sun J Chung
Journal:  J Mov Disord       Date:  2013-05-30

8.  Piericidin A aggravates Tau pathology in P301S transgenic mice.

Authors:  Matthias Höllerhage; Roman Deck; Anderson De Andrade; Gesine Respondek; Hong Xu; Thomas W Rösler; Mohamed Salama; Thomas Carlsson; Elizabeth S Yamada; Seham A Gad El Hak; Michel Goedert; Wolfgang H Oertel; Günter U Höglinger
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

9.  Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental Phenotypes.

Authors:  An Verheyen; Annick Diels; Joke Reumers; Kirsten Van Hoorde; Ilse Van den Wyngaert; Constantin van Outryve d'Ydewalle; An De Bondt; Jacobine Kuijlaars; Louis De Muynck; Ronald De Hoogt; Alexis Bretteville; Steffen Jaensch; Arjan Buist; Alfredo Cabrera-Socorro; Selina Wray; Andreas Ebneth; Peter Roevens; Ines Royaux; Pieter J Peeters
Journal:  Stem Cell Reports       Date:  2018-07-26       Impact factor: 7.765

Review 10.  The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.

Authors:  Elisa Ridolfi; Cinzia Barone; Elio Scarpini; Daniela Galimberti
Journal:  Clin Dev Immunol       Date:  2013-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.